GLP-2 (Tirzepatide) 30mg research peptide vial
Tirzepatide

Lot #260626TZ303

Price range: $110.00 through $280.50
$80.00

Dual GIP/GLP-1 Receptor Agonist (Tirzepatide)

GLP-2 [30mg]

30mg / vial

Dual incretin receptor agonist

≥99% HPLC

4.9 / 5

Trusted by 5,000+ researchers

30-day money back

2-day shipping

Signed COA on every batch

Secure checkout

Price range: $110.00 through $280.50
$80.00

View Certificate of Analysis

COA on Every Batch

BioRegen Verified

≥99% HPLC Purity

Made in the USA

2-Day Shipping

30-Day Money Back

Compound Profile

Researcher-grade specs. No guesswork.

Each vial ships with structural data and lot identifiers for the compound, plus a Certificate of Analysis documenting purity and identity. Ready for the bench. Synthesized via solid-phase peptide synthesis (SPPS), purified by reverse-phase HPLC, verified by mass spectrometry, and tested for sterility and endotoxin load. Every spec is documented on the signed Certificate of Analysis that ships with your vial.

View signed COA
— Component 01
Tirzepatide · 30mg
Class
Dual GIP/GLP-1 receptor agonist
Sequence
Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys(C20 fatty diacid via linker)-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser (39 aa)
CAS Number
2023788-19-2
Molecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight
4,813.5 g/mol
Per-component purity
≥ 98%
In the Literature

One compound. One research record.

Tirzepatide is a 39-amino acid synthetic peptide that acts as a dual agonist at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

The molecule is built on a GIP receptor-binding scaffold with GLP-1 receptor agonist activity incorporated via sequence modification, enabling simultaneous activation of both incretin receptors. Published research has examined receptor pathway activity and metabolic signaling associated with this dual-agonist mechanism.

This product is for laboratory research use only. Not for human administration. Not intended to diagnose, treat, cure, or prevent any disease.

For research use only. Statements above describe published research literature and do not constitute health, medical, or therapeutic claims for either compound or for the blend. Not for human or veterinary use. Not evaluated by the FDA.

Documented Research Areas

  • Dual GIP and GLP-1 receptor binding and co-activation in vitro receptor assays
  • Comparative GIP/GLP-1 receptor agonism versus single-receptor incretin analogs
  • Glucose-dependent insulin secretion and beta-cell function in preclinical models
  • Body weight modulation and adipose tissue remodeling in diet-induced obesity models
  • Incretin receptor pathway interaction and dual-agonism synergy characterization

Selected Studies · Peer-Reviewed Literature

A curated list of published peer-reviewed papers indexed in PubMed where BPC-157 has been studied. Provided for research-context only. Linking to the literature does not constitute endorsement of any therapeutic application.

01

Frias JP, et al. · N Engl J Med

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

PubMed · PubMed · 34170647
02

Jastreboff AM, et al. · N Engl J Med

Tirzepatide Once Weekly for the Treatment of Obesity

PubMed · PubMed · 35658024

Compound database reference for chemical and structural data:

PubChem CID 9941957
Transparency

Every lot. Every researcher. Same proof.

Each batch ships with a third-party Certificate of Analysis from BioRegen Analytical. HPLC purity, mass-spectrometry identity, sterility, and LAL endotoxin screening. Every test, every lot.

Your lot number ships on the label and on the COA. Enter it in the verifier any time to retrieve the original lab report.

Verify Batch COA
Download Sample COA

Certificate of Analysis

  • 30mg / vial
  • Dual incretin receptor agonist
  • Lot #260626TZ303

CompoundTirzepatide
CAS#2023788-19-2
FormulaC₂₂₅H₃₄₈N₄₈O₆₈
Mol. Weight4,813.5 g/mol
Identity (LC-MS)PASS
Purity (HPLC)99.492%
Sterility / LALPASS
Date Tested11 Jul 2026

Pairs With

Related compounds.

Other research peptides in the Elixser catalog cited alongside the BPC-157 + TB-500 blend in the published research literature.

TB-500 [10mg]

10mg / single compound

Research use only · Not for human or veterinary use

Price range: $40.00 through $102.00
Price range: $40.00 through $80.00

View →

OXYTOCIN [10mg]

10mg / single compound

Research use only · Not for human or veterinary use

Price range: $35.00 through $89.25
Price range: $35.00 through $80.00

View →

SEMAX [10mg]

10mg / single compound

Research use only · Not for human or veterinary use

Price range: $35.00 through $89.25
Price range: $35.00 through $80.00

View →
Common Questions

Answered straight.

Ready to Order

Add the GLP-2 [30mg] blend to your research arsenal.

5,000+ researchers trust Elixser for batch-tested peptides. Every vial. Every COA. Every time.

Add to Cart

30-day money back · Free shipping over $150 · 2-day shipping

Signed COA on every batch